Genomic Health (GHDX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $82.3 million versus the consensus estimate of $83.24 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Is Treasury selloff a major issue for stock market bulls?
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
